Royalty Pharma PLC
XBER:RPD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Royalty Pharma PLC
XBER:RPD
|
US |
|
A
|
Arlo Technologies Inc
F:2VI
|
US |
|
Gladstone Land Corp
F:3L4
|
US |
|
Nagase & Co Ltd
TSE:8012
|
JP |
|
C
|
CNH Industrial NV
SWB:37C
|
UK |
|
I
|
Immersion Corp
SWB:IMV
|
US |
|
J
|
Jai Balaji Industries Ltd
BSE:532976
|
IN |
|
SIA Engineering Company Ltd
SGX:S59
|
SG |
Wall St Price Targets
RPD Price Targets Summary
Royalty Pharma PLC
According to Wall Street analysts, the average 1-year price target for RPD is 41.71 EUR with a low forecast of 33.2 EUR and a high forecast of 49.52 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RPD's stock price target?
Price Target
41.71
EUR
According to Wall Street analysts, the average 1-year price target for RPD is 41.71 EUR with a low forecast of 33.2 EUR and a high forecast of 49.52 EUR.
What is the Revenue forecast for Royalty Pharma PLC?
Projected CAGR
16%
Over the last 7 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 16%.
What is the Operating Income forecast for Royalty Pharma PLC?
Projected CAGR
12%
Over the last 7 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 12%.
What is the Net Income forecast for Royalty Pharma PLC?
Projected CAGR
31%
Over the last 7 years, the compound annual growth rate for Net Income has been -8%. The projected CAGR for the next 7 years is 31%.
